We investigated the role of GPNMB as a potential biomarker for DM-related cataract based on the data and samples collected from an ongoing cohort study—China Aging Longitudinal Study (CALS)—that enrolled a total of 26,000 healthy Chinese residents from seven geographic areas with the aim to investigate health and aging trends in China. This evidence concerns the gene GPNMB and diabetes mellitus.